ChemBK
  • Home
  • Product Category


Lomitapide Mesylate

Lomitapide Mesylate

CAS: 202914-84-9

Molecular Formula: C40H41F6N3O5S

  1. Home
  2. Product Category
  3. Organic raw materials
  4. carboxylic acid
  5. Lomitapide Mesylate

Lomitapide Mesylate - Names and Identifiers

Name Lomitapide Mesylate
Synonyms BMS 201038-04
AEGR733 Mesylate
AEGR-733 Mesylate
AEGR 733 Mesylate
BMS201038 Mesylate
BMS 201038 Mesylate
LoMitapide Mesylate
Lomitapide Mesylate
BMS 201038 methanesulfonic acid salt
9H-Fluorene-9-carboxamide, N-(2,2,2-trifluoroethyl)-9-[4-[4-[[[4'-(trifluoromethyl)[1,1'-biphenyl]-2-yl]car bonyl]amino]-1-piperidinyl]butyl]-, methanesulfonate
CAS 202914-84-9

Lomitapide Mesylate - Physico-chemical Properties

Molecular FormulaC40H41F6N3O5S
Molar Mass789.8260592
Solubility 10 mM in DMSO
Storage ConditionInert atmosphere,Room Temperature
UseLomitapide is a MTP inhibitor. Lomitapid is a novel agent for the treatment of homozygous familial hypercholesterolemia. Lomitapide is an orally active inhibitor of microsomal triglyceride transfer protein that is indicated as an adjunct to a low-fat diet and other lipid-lowering treatments, including LDL apheresis where available for the reduction of LDL-C, total cholesterol, apolipoprotein B, and non-high-density lipoprotein cholesterol in adult patients with HoFH.
TargetMTP

Lomitapide Mesylate - Reference

Reference
Show more
1: Marbach JA, Thapa J, Goldenberg E, Duffy D. Pharmacogenetics in the Development of Lipid Lowering Medications: Lomitapide & Mipomersen in Clinical Practice. Del Med J. 2015 Aug;87(8):238-43. PubMed PMID: 26402926.
2: Roeters van Lennep J, Averna M, Alonso R. Treating homozygous familial hypercholesterolemia in a real-world setting: Experiences with lomitapide. J Clin Lipidol. 2015 Jul-Aug;9(4):607-17. doi: 10.1016/j.jacl.2015.05.001. Epub 2015 May 14. PubMed PMID: 26228681.
3: Patel G, King A, Dutta S, Korb S, Wade JR, Foulds P, Sumeray M. Evaluation of the effects of the weak CYP3A inhibitors atorvastatin and ethinyl estradiol/norgestimate on lomitapide pharmacokinetics in healthy subjects. J Clin Pharmacol. 2015 Jun 26. doi: 10.1002/jcph.581. [Epub ahead of print] PubMed PMID: 26120010.
4: Gouni-Berthold I, Berthold HK. Mipomersen and lomitapide: Two new drugs for the treatment of homozygous familial hypercholesterolemia. Atheroscler Suppl. 2015 May;18:28-34. doi: 10.1016/j.atherosclerosissup.2015.02.005. PubMed PMID: 25936301.
5: Stefanutti C, Blom DJ, Averna MR, Meagher EA, Theron Hd, Marais AD, Hegele RA, Sirtori CR, Shah PK, Gaudet D, Vigna GB, Sachais BS, Di Giacomo S, du Plessis AM, Bloedon LT, Balser J, Rader DJ, Cuchel M; Phase 3 HoFH Lomitapide Study Investigators. The lipid-lowering effects of lomitapide are unaffected by adjunctive apheresis in patients with homozygous familial hypercholesterolaemia - a post-hoc analysis of a Phase 3, single-arm, open-label trial. Atheros

Lomitapide Mesylate - Preparation solution concentration reference

 1mg5mg10mg
1 mM1.266 ml6.331 ml12.661 ml
5 mM0.253 ml1.266 ml2.532 ml
10 mM0.127 ml0.633 ml1.266 ml
5 mM0.025 ml0.127 ml0.253 ml
Last Update:2024-01-02 23:10:35
Lomitapide Mesylate
Supplier List
Shanghai Macklin Biochemical Co., Ltd
Featured ProductsSpot supply
Product Name: Lomitapide Mesylate Visit Supplier Webpage Request for quotation
CAS: 202914-84-9
Tel: +86-18821248368
Email: Int06@meryer.com
Mobile: +86-18821248368
QQ: 495145328 Click to send a QQ message
WhatsApp: +86-18821248368
Shanghai Amole Biotechnology Co., Ltd.
Spot supply
Product Name: Lomitapidemesylate Request for quotation
CAS: 202914-84-9
Tel: 400-968-2212
Email: 3623107365@qq.com
Mobile: 18916960931
QQ: 3623107365 Click to send a QQ message
Wechat: 18916960931
SHANGHAI ACMEC BIOCHEMICAL TECHNOLOGY CO., LTD.
Spot supply
Product Name: Lomitapide (mesylate) Visit Supplier Webpage Request for quotation
CAS: 202914-84-9
Tel: +86-400-900-4166
Email: product@acmec-e.com
Mobile: +86-18621343501
QQ: 2881950922 Click to send a QQ message
Wechat: 18621343501
WhatsApp: +86-18621343501
MedChemExpress (MCE)
Multiple SpecificationsSpot supply
Product Name: AEGR-733 mesylate; BMS-201038 mesylate Visit Supplier Webpage Request for quotation
CAS: 202914-84-9
Tel: 609-228-6898
Email: sales@medchemexpress.com
     tech@medchemexpress.com
Mobile: 609-228-6898
Shanghai Yuanye Bio-Technology Co., Ltd.
Product Name: Lomitapide (mesylate) Visit Supplier Webpage Request for quotation
CAS: 202914-84-9
Tel: 18301782025
Email: 3008007409@qq.com
Mobile: 18021002903
QQ: 3008007409 Click to send a QQ message
Shanghai Macklin Biochemical Co., Ltd
Featured ProductsSpot supply
Product Name: Lomitapide Mesylate Visit Supplier Webpage Request for quotation
CAS: 202914-84-9
Tel: +86-18821248368
Email: Int06@meryer.com
Mobile: +86-18821248368
QQ: 495145328 Click to send a QQ message
WhatsApp: +86-18821248368
Shanghai Amole Biotechnology Co., Ltd.
Spot supply
Product Name: Lomitapidemesylate Request for quotation
CAS: 202914-84-9
Tel: 400-968-2212
Email: 3623107365@qq.com
Mobile: 18916960931
QQ: 3623107365 Click to send a QQ message
Wechat: 18916960931
SHANGHAI ACMEC BIOCHEMICAL TECHNOLOGY CO., LTD.
Spot supply
Product Name: Lomitapide (mesylate) Visit Supplier Webpage Request for quotation
CAS: 202914-84-9
Tel: +86-400-900-4166
Email: product@acmec-e.com
Mobile: +86-18621343501
QQ: 2881950922 Click to send a QQ message
Wechat: 18621343501
WhatsApp: +86-18621343501
MedChemExpress (MCE)
Multiple SpecificationsSpot supply
Product Name: AEGR-733 mesylate; BMS-201038 mesylate Visit Supplier Webpage Request for quotation
CAS: 202914-84-9
Tel: 609-228-6898
Email: sales@medchemexpress.com
     tech@medchemexpress.com
Mobile: 609-228-6898
Shanghai Yuanye Bio-Technology Co., Ltd.
Product Name: Lomitapide (mesylate) Visit Supplier Webpage Request for quotation
CAS: 202914-84-9
Tel: 18301782025
Email: 3008007409@qq.com
Mobile: 18021002903
QQ: 3008007409 Click to send a QQ message
View History
Lomitapide Mesylate
HEXENYL-CIS-3-ISO-VALERATE
74675-22-2
2-hydroxy-2-methylpropionaldehyde
Niobium chloride (NbCl5)
VINYL CYANIDE
Nsc 41936
  • Home
  • Product Category

© 2015, 2023 ChemBK.com All Rights Reserved | Build: 20230617001